Cargando…
Examining the Psychoactive Differences between Kratom Strains
Kratom (Mitragyna speciosa) is a Southeast Asian plant containing various alkaloids that induce pharmacological effects in humans. In Western countries, online vendors sell a variety of different kratom strains which are marketed to have distinct effect profiles. However, as of yet such marketing cl...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379209/ https://www.ncbi.nlm.nih.gov/pubmed/37510657 http://dx.doi.org/10.3390/ijerph20146425 |
_version_ | 1785079958084780032 |
---|---|
author | Huisman, Guido Menke, Maximilian Grundmann, Oliver Schreiber, Rudy Mason, Natasha |
author_facet | Huisman, Guido Menke, Maximilian Grundmann, Oliver Schreiber, Rudy Mason, Natasha |
author_sort | Huisman, Guido |
collection | PubMed |
description | Kratom (Mitragyna speciosa) is a Southeast Asian plant containing various alkaloids that induce pharmacological effects in humans. In Western countries, online vendors sell a variety of different kratom strains which are marketed to have distinct effect profiles. However, as of yet such marketing claims are unsubstantiated, and therefore the current study investigated whether differently colored kratom products can induce distinct effects, as self-reported by users. Six hundred forty-four current kratom users were anonymously surveyed to compare the self-reported effects of and motivations for using kratom products sold as red, green, and white strains. Most of the survey respondents were customers of the same kratom vendor, the products of which had been analyzed for their alkaloid content by an independent laboratory. The survey respondents reported distinct subjective experiences for different kratom strains, in a manner congruent with common marketing descriptions. However, the product analyses revealed no significant cross-strain differences in alkaloid content, suggesting that the reported effect differences might be disproportionally influenced by marketing narratives and anecdotal reports. Future studies should engage a more diverse population and include kratom strains from various vendors. Controlled, blinded experiments could assess whether the reported effect differences stem from a placebo effect or from alternative factors, e.g., minor alkaloids and terpenes. |
format | Online Article Text |
id | pubmed-10379209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103792092023-07-29 Examining the Psychoactive Differences between Kratom Strains Huisman, Guido Menke, Maximilian Grundmann, Oliver Schreiber, Rudy Mason, Natasha Int J Environ Res Public Health Article Kratom (Mitragyna speciosa) is a Southeast Asian plant containing various alkaloids that induce pharmacological effects in humans. In Western countries, online vendors sell a variety of different kratom strains which are marketed to have distinct effect profiles. However, as of yet such marketing claims are unsubstantiated, and therefore the current study investigated whether differently colored kratom products can induce distinct effects, as self-reported by users. Six hundred forty-four current kratom users were anonymously surveyed to compare the self-reported effects of and motivations for using kratom products sold as red, green, and white strains. Most of the survey respondents were customers of the same kratom vendor, the products of which had been analyzed for their alkaloid content by an independent laboratory. The survey respondents reported distinct subjective experiences for different kratom strains, in a manner congruent with common marketing descriptions. However, the product analyses revealed no significant cross-strain differences in alkaloid content, suggesting that the reported effect differences might be disproportionally influenced by marketing narratives and anecdotal reports. Future studies should engage a more diverse population and include kratom strains from various vendors. Controlled, blinded experiments could assess whether the reported effect differences stem from a placebo effect or from alternative factors, e.g., minor alkaloids and terpenes. MDPI 2023-07-21 /pmc/articles/PMC10379209/ /pubmed/37510657 http://dx.doi.org/10.3390/ijerph20146425 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Huisman, Guido Menke, Maximilian Grundmann, Oliver Schreiber, Rudy Mason, Natasha Examining the Psychoactive Differences between Kratom Strains |
title | Examining the Psychoactive Differences between Kratom Strains |
title_full | Examining the Psychoactive Differences between Kratom Strains |
title_fullStr | Examining the Psychoactive Differences between Kratom Strains |
title_full_unstemmed | Examining the Psychoactive Differences between Kratom Strains |
title_short | Examining the Psychoactive Differences between Kratom Strains |
title_sort | examining the psychoactive differences between kratom strains |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379209/ https://www.ncbi.nlm.nih.gov/pubmed/37510657 http://dx.doi.org/10.3390/ijerph20146425 |
work_keys_str_mv | AT huismanguido examiningthepsychoactivedifferencesbetweenkratomstrains AT menkemaximilian examiningthepsychoactivedifferencesbetweenkratomstrains AT grundmannoliver examiningthepsychoactivedifferencesbetweenkratomstrains AT schreiberrudy examiningthepsychoactivedifferencesbetweenkratomstrains AT masonnatasha examiningthepsychoactivedifferencesbetweenkratomstrains |